A Summary of the Final Rule of the Lymphedema Treatment Act Recently Released by CMS

Published in Government Relations on November 05, 2023

CMS has released their final rule regarding the implementation of the Lymphedema Treatment Act, which outlines how they intend to begin covering compression garments and related accessories for patients diagnosed with lymphedema. The full 65-page document can be viewed here. (beginning on page 350). Below is a summary of some of the key provisions of the final rule:

Covered items: The following items will be covered by Medicare beginning January 1, 2024 for patients diagnosed with lymphedema:

  • both standard and custom fitted gradient compression garments
  • gradient compression wraps with adjustable straps
  • compression bandaging systems
  • other items determined to be lymphedema compression treatment items

Frequency limitations: Medicare will cover:

  • 3 (three) daytime garments or wraps with adjustable straps for each affected limb or area of the body, replaced every 6 months.
  • 2 (two) nighttime garments for each affected limb or area of the body, replaced once every 2 years.
    • *These limitations are higher than what was originally suggested in the proposed rule, and industry stakeholder comments played a key role in raising the frequency limitations that were finalized.

HCPCS Codes: There are a couple tables contained within the final rule, namely tables FF-A 1 and FF-A 2, which outline the codes that will be used to represent many of the compression related products used to treat patients with lymphedema.

  • CMS is keeping several of the existing compression codes that several of you may already be familiar with (A6530-A6549 range). These are outlined in Table FF-A 1 on page 372.
  • CMS is creating 57 new HCPCS codes to better represent additional lymphedema related compression products. These new HCPCS codes have yet to be determined, but the descriptions of each new code can be found in Table FF-A 2 on page 389.
  • CMS is creating 9 additional new A-codes to replace 9 existing S-codes (S8420-S8428) that currently represent compression sleeves, gloves, gauntlets, wraps, and bandages.

Pricing/Reimbursement: CMS has not yet finalized the full fee schedule for all of the compression codes. They have, however, provided some example pricing for some codes in table FF-A 3 (page 398). They also stated that “Final payment amounts will be determined in accordance with the methodology as previously detailed based on the most recent data available in late 2023 and will most likely be higher than these example payment amounts.” They also stated that they will use available pricing data from Medicaid, VHA, TRICARE, and internet retailers in establishing allowables for these items.


VGM will continue to monitor the information that is released regarding this topic, and will provide you with additional updates as appropriate. Please don’t hesitate to reach out to our Government and Regulatory team at 800-642-6065 if you have additional questions.

From Our Experts

The Big Sky Association of Medical Equipment Suppliers Welcomes UTAH! thumbnail The Big Sky Association of Medical Equipment Suppliers Welcomes UTAH! The Big Sky Association of Medical Equipment Suppliers is pleased to announce that Utah has officially been accepted into the association as our newest participating state. Big Sky now proudly welcomes all Utah DME/HME, Respiratory, CRT, and Medical Supply companies into our regional association. Utah will have a designated state representative/director—appointed in the same manner as Montana, Idaho, and Wyoming—to ensure strong representation and a clear voice within the Association. Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry thumbnail Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry While the government shutdown and uncertainty surrounding CMS's Proposed Rule have dominated headlines, several important bills impacting HME providers continue to advance. Here's a quick look at three focused legislative priorities: Advocacy in Action: Texas DME Providers Stand Up For Patient Care thumbnail Advocacy in Action: Texas DME Providers Stand Up For Patient Care Texas DME providers are speaking out against proposed Medicaid reimbursement rate cuts that threaten access to essential medical equipment for vulnerable patients. At a recent public hearing, voices from across the state shared powerful stories about the real-world impact of these cuts—some as high as 85%. The Shutdown Has Ended—Now It's Time To Take Action thumbnail The Shutdown Has Ended—Now It's Time To Take Action The recent government shutdown created uncertainty across the healthcare landscape, and the DMEPOS community was no exception. In the weeks ahead, critical decisions will shape the future of our industry. By getting involved early—through advocacy, education, and collaboration—you can help ensure these policies support patients and providers rather than hinder them. Notably, the Continuing Resolution (CR) includes an extension of Medicare telehealth flexibilities through January 2026... New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed. Champions of Change: DME Advocates Driving Real Change thumbnail Champions of Change: DME Advocates Driving Real Change Real change starts with real people. In this edition of Champions of Change, we're spotlighting two DME advocates who aren't just talking about problems—they're taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry. Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program.